Plant ID: NPO29118
Plant Latin Name: Euonymus Alatus
Taxonomy Genus: Euonymus
Taxonomy Family: Celastraceae
NCBI TaxonomyDB:
4307
Plant-of-the-World-Online:
n.a.
Anodyne; Anthelmintic; Antiphlogistic; Antipruritic; Astringent; Blood tonic; Cancer; Carminative; Emmenagogue; Hypoglycaemic
South Korea; China
Ingredient ID: NPC98680
Ingredient ID: NPC95615
Ingredient ID: NPC92507
Ingredient ID: NPC87725
Ingredient ID: NPC84810
Ingredient ID: NPC82920
Ingredient ID: NPC81186
Ingredient ID: NPC79943
Ingredient ID: NPC7903
Ingredient ID: NPC63118
Ingredient ID: NPC6300
Ingredient ID: NPC62765
Ingredient ID: NPC62290
Ingredient ID: NPC61477
Ingredient ID: NPC52686
Ingredient ID: NPC50898
Ingredient ID: NPC470098
Ingredient ID: NPC470097
Ingredient ID: NPC470096
Ingredient ID: NPC470095
Ingredient ID: NPC3862
Ingredient ID: NPC35208
Ingredient ID: NPC35069
Ingredient ID: NPC32441
Ingredient ID: NPC314267
Ingredient ID: NPC311485
Ingredient ID: NPC310604
Ingredient ID: NPC305186
Ingredient ID: NPC300166
Ingredient ID: NPC29883
Ingredient ID: NPC297815
Ingredient ID: NPC295992
Ingredient ID: NPC294902
Ingredient ID: NPC292056
Ingredient ID: NPC290791
Ingredient ID: NPC289660
Ingredient ID: NPC287657
Ingredient ID: NPC283217
Ingredient ID: NPC277924
Ingredient ID: NPC277493
Ingredient ID: NPC277400
Ingredient ID: NPC275463
Ingredient ID: NPC274613
Ingredient ID: NPC266441
Ingredient ID: NPC265800
Ingredient ID: NPC263367
Ingredient ID: NPC263261
Ingredient ID: NPC263124
Ingredient ID: NPC26065
Ingredient ID: NPC260397
Ingredient ID: NPC256853
Ingredient ID: NPC250486
Ingredient ID: NPC24490
Ingredient ID: NPC243728
Ingredient ID: NPC239128
Ingredient ID: NPC237727
Ingredient ID: NPC237031
Ingredient ID: NPC227017
Ingredient ID: NPC219876
Ingredient ID: NPC209360
Ingredient ID: NPC20791
Ingredient ID: NPC199914
Ingredient ID: NPC192638
Ingredient ID: NPC192065
Ingredient ID: NPC187107
Ingredient ID: NPC184447
Ingredient ID: NPC184248
Ingredient ID: NPC183181
Ingredient ID: NPC182570
Ingredient ID: NPC180261
Ingredient ID: NPC1788
Ingredient ID: NPC17879
Ingredient ID: NPC1786
Ingredient ID: NPC176740
Ingredient ID: NPC165172
Ingredient ID: NPC164697
Ingredient ID: NPC162806
Ingredient ID: NPC156654
Ingredient ID: NPC15658
Ingredient ID: NPC156502
Ingredient ID: NPC156353
Ingredient ID: NPC153783
Ingredient ID: NPC147821
Ingredient ID: NPC145134
Ingredient ID: NPC141765
Ingredient ID: NPC137419
Ingredient ID: NPC133990
Ingredient ID: NPC12640
Ingredient ID: NPC122212
Ingredient ID: NPC116775
Ingredient ID: NPC111888
Ingredient ID: NPC111247
Ingredient ID: NPC111201
Ingredient ID: NPC110899
Ingredient ID: NPC108831
Ingredient ID: NPC1075
Ingredient ID: NPC10737
Ingredient ID: NPC1037
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 | Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 | Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 | Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Enzyme | CES1 | Acyl coenzyme A:cholesterol acyltransferase | P23141 | CHEMBL2265 |
Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Therapeutic Target | Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Therapeutic Target | Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Therapeutic Target | Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Therapeutic Target | Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Therapeutic Target | Nicotinic acetylcholine receptor | CHRNA3 | Neuronal acetylcholine receptor subunit alpha-3 | P32297 | CHEMBL3068 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Therapeutic Target | Oxidoreductase | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | P14061 | CHEMBL3181 |
Therapeutic Target | Oxidoreductase | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Therapeutic Target | Protein Kinase | MKNK2 | MAP kinase signal-integrating kinase 2 | Q9HBH9 | CHEMBL4204 |
Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Therapeutic Target | Protein Kinase | CSNK2A1 | Casein kinase II alpha | P68400 | CHEMBL3629 |
Therapeutic Target | Protein Kinase | YES1 | Tyrosine-protein kinase YES | P07947 | CHEMBL2073 |
Therapeutic Target | Protein Kinase | AXL | Tyrosine-protein kinase receptor UFO | P30530 | CHEMBL4895 |
Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Therapeutic Target | Secreted protein | TTR | Transthyretin | P02766 | CHEMBL3194 |
Therapeutic Target | Serine protease | DPP4 | Dipeptidyl peptidase IV | P27487 | CHEMBL284 |
Therapeutic Target | Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 281 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00296647 | Smoking Cessation Intervention: Effectiveness in Primary Care | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04999644 | Reduced Nicotine Cigarette Purchasing Decisions | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02501265 | Adaptive Pharmacotherapy for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01806779 | Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03290430 | End Nicotine Dependence Clinic | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01348204 | Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators | cystic fibrosis | Quercetin (NPC20791) | NP level |
NCT05154669 | Integrating Financial Coaching and Smoking Cessation Coaching | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04709471 | E-cigarette Nicotine Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03178422 | Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01429129 | Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00507975 | Study of Nicotine Patch in Pregnancy (SNIPP) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03262233 | Stress Neuroadaptation in Tobacco Dependence | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01702532 | Nicotine Mouth Film for Craving Relief. | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00469079 | Health Effects of SLT, Cigarette Smoking, and New Tobacco Products | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02720445 | Memory Improvement Through Nicotine Dosing (MIND) Study | Cognitive impairment | Nicotine (NPC182570) | NP level |
NCT00218283 | Nicotine Lozenge to Reduce Smokeless Tobacco Use | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03163303 | Smoking Tobacco and Drinking Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01296698 | Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01502306 | A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline | smoking cessation | Nicotine (NPC182570) | NP level |
NCT02896400 | Optimizing Tobacco Dependence Treatment in the Emergency Department | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05233228 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02681510 | UW-CTRI Triple Medication Smoking Cessation Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00132236 | Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support | chronic obstructive pulmonary disease;nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04488744 | Smoking by IV Pulsed Nicotine | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | childhood cancer | Quercetin (NPC20791) | NP level |
NCT01560754 | Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease | Parkinson disease | Nicotine (NPC182570) | NP level |
NCT03611881 | Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03408574 | The Nicotinic Cholinergic System and Cognitive Aging | aging | Nicotine (NPC182570) | NP level |
NCT00851357 | Telephone Counseling and the Distribution of Nicotine Patches to Smokers | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01314001 | Pharmacogenetics of Nicotine Addiction Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03176784 | UW Quitting Using Intensive Treatment Study (QUITS) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04124432 | Behavioral Pharmacology of Cannabis and Nicotine | cannabis dependence | Nicotine (NPC182570) | NP level |
NCT02232737 | Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04598594 | Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients | COVID-19;severe acute respiratory syndrome | Nicotine (NPC182570) | NP level |
NCT01047527 | An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01104896 | Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00392379 | Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02997657 | Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00295984 | Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma | sarcoma | Nicotine (NPC182570) | NP level |
NCT00793468 | Relapse Prevention Study in Newly Abstinent Smokers | substance dependence | Nicotine (NPC182570) | NP level |
NCT00833404 | Smoking Cessation and Sexual Health in Men | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00067158 | Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00000444 | Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01839344 | Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. | type 2 diabetes mellitus | Quercetin (NPC20791) | NP level |
NCT00894166 | Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00957918 | Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy | Parkinson disease | Nicotine (NPC182570) | NP level |
NCT03580525 | Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01351766 | Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01034020 | Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01208935 | Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03860077 | Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00956943 | Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03000387 | Personalized Dosing of Nicotine Replacement (NRT to Effect) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00699556 | Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy | alcohol drinking | Nicotine (NPC182570) | NP level |
NCT01539434 | Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Nicotine (NPC182570) | NP level |
NCT00297492 | Gradual vs. Abrupt Cessation Treatment for Smoking | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03612960 | Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00777569 | Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01838460 | Sublingual Nicotine Tablets Compared With Swedish Snus | smoking cessation | Nicotine (NPC182570) | NP level |
NCT02482233 | The END Perioperative Smoking Pilot Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00018161 | Treatment to Quit Smoking | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01819259 | Nicotine, Non-Smokers With and Without ADHD, and Genetics Study | attention deficit hyperactivity disorder | Nicotine (NPC182570) | NP level |
NCT02927847 | Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03856515 | Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes | carcinoma | Nicotine (NPC182570) | NP level |
NCT02371850 | Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01085032 | Nicotine Patch Trial in Syrian Primary Care Settings | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03543137 | To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05024747 | A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02964182 | Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03272685 | Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00664755 | Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03521141 | PRecision Interventions for SMoking in the SCCS | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00967174 | Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01506908 | Provoked Craving Assessment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05176418 | IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00018187 | Combinations of Pharmacologic Smoking Cessation Treatments | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04907253 | Quercetin in Coronary Artery By-pass Surgery | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT02250534 | Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03808818 | Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices | in situ carcinoma | Nicotine (NPC182570) | NP level |
NCT01018394 | Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02081144 | Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01708278 | Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT00004551 | Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03541044 | A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03897439 | Individualizing Pharmacotherapy for African American Smokers | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00775944 | Trial Comparing Different Methods of Support With Stopping Smoking (PORTSSS/Stop Together Trial) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05018117 | Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex | aging | Nicotine (NPC182570) | NP level |
NCT04490057 | A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03879889 | Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00616746 | Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans | alcohol drinking | Nicotine (NPC182570) | NP level |
NCT03404596 | Applying mHealth to Tobacco-related Health Disparities | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01867411 | Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01741701 | A Pilot Study of Oxaloacetate in Subjects With Treated PD | Parkinson disease | Oxaloacetate (NPC1037) | NP level |
NCT02955329 | Vaping THC From Electronic Cigarettes | cannabis dependence | Nicotine (NPC182570) | NP level |
NCT01048944 | Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00888459 | A Pilot Study Evaluating Nicotine Lozenges and Self Help | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02356913 | Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00553709 | Study of Nicotine for the Prevention of PONV | post operative nausea and vomiting | Nicotine (NPC182570) | NP level |
NCT00879918 | Pharmacogenetics of Nicotine Metabolism in African-Americans | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01517022 | Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis | tuberculosis | Nicotine (NPC182570) | NP level |
NCT04262817 | The Interaction of Flavor With Nicotine Form in Adult Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05487807 | Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01621022 | Bupropion Alone or Combined With Nicotine Gum | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04946825 | Quit Smoking Study for People Who Use E-Cigarettes | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04994444 | Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03538938 | Improving Quitline Support Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00527020 | First Time in Human Study With GSK1018921 | schizophrenia | Nicotine (NPC182570) | NP level |
NCT00061074 | Tobacco Cessation in Postmenopausal Women (Part II) - 2 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01669122 | Pharmacokinetic Study of 4 mg Nicotine Lozenge. | smoking cessation | Nicotine (NPC182570) | NP level |
NCT02271919 | Varenicline and Combined NRT for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02840435 | Study on Sit to Quit Phone Intervention | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04003805 | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05335915 | Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00000437 | Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01303861 | Concurrent Bupropion / Varenicline for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05276895 | Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis | osteoarthritis | Quercetin (NPC20791) | NP level |
NCT02587312 | Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01287377 | Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00715871 | Clinical Study of Smoke-Break Liquid Cigarettes | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01321931 | Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02521662 | The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03442413 | Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01736085 | Providing Free Nicotine Patches to Quitline Smokers | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04590404 | Metabolism Informed Smoking Treatment: The MIST RCT | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05236894 | Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population | carcinoma | Nicotine (NPC182570) | NP level |
NCT02351622 | Caffeic Acid Tablets as a Second-line Therapy for ITP | autoimmune thrombocytopenic purpura | Caffeic Acid (NPC294902) | NP level |
NCT04204889 | Trial of Oxaloacetate in ALS | amyotrophic lateral sclerosis | Oxaloacetate (NPC1037) | NP level |
NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Quercetin (NPC20791) | NP level |
NCT04084210 | Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03635333 | Effects of E-Cigarette Flavors on Adults TCORS 2.0 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02511704 | Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01783912 | Helping Those With Mental Illness Quit Smoking | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01372254 | Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03069482 | Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04290897 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | breast carcinoma in situ | Oxaloacetate (NPC1037) | NP level |
NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | COVID-19 | Quercetin (NPC20791) | NP level |
NCT02226484 | Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | gastroesophageal reflux disease | Quercetin (NPC20791) | NP level |
NCT05311085 | Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion) | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01136642 | Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02721082 | Changing the Default for Tobacco Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00018148 | Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03482583 | Tobacco Use Treatment in Cancer Patients | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00840242 | Smoking Reduction or Cessation With Nicotine Replacement Therapy | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01907594 | Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01172561 | Community Awareness Resources and Education - Project 1 | cervical cancer | Nicotine (NPC182570) | NP level |
NCT01857531 | Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04433767 | Depressed Mood Improvement Through Nicotine Dosing 2 | depressive disorder | Nicotine (NPC182570) | NP level |
NCT02439944 | Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00960778 | Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01091363 | Tobacco Dependence Treatment for Asian Americans | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02018263 | Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans | cocaine dependence | Nicotine (NPC182570) | NP level |
NCT02019459 | Very Low Nicotine Cigarettes in Smokers With Schizophrenia | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00744913 | Study of Nicotine Replacement Therapy in Pregnancy | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00000447 | Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01926626 | Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02179034 | Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05159934 | Nicotine Differences in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01199380 | Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00086411 | Comparing Smoking Treatment Programs for Lighter Smokers - 1 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03972137 | Heart Rate Variability Biofeedback for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01417429 | Galantamine Effects on Nicotine Responses in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01664741 | Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05351606 | Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00969137 | Sensitivity to Intravenous Nicotine: Genetic Moderators | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | prostate adenocarcinoma | Quercetin (NPC20791) | NP level |
NCT04608201 | Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients | COVID-19 | Nicotine (NPC182570) | NP level |
NCT00657020 | Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03943459 | Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT01892813 | Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01438320 | Q-Trial in Patients With Hepatitis C | chronic hepatitis C virus infection | Quercetin (NPC20791) | NP level |
NCT03432273 | Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01292642 | Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine Dependence | cannabis dependence;nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01705652 | Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients | prostate cancer | Rutin (NPC176740) | NP level |
NCT04696380 | Do Flavors Increase the Addiction Potential of Nicotine? | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00939029 | Highdose Nicotine Patch Therapy for Smokeless Tobacco Use | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01065506 | Smoking Termination Enhancement Project (STEP) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02250664 | Project 2, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Opioid Abusers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00873392 | Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease | Parkinson disease | Nicotine (NPC182570) | NP level |
NCT02906644 | Combination Nicotine Patch / Lorcaserin for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00543881 | Telemedical Interventional Monitoring in Heart Failure | heart failure | Nicotine (NPC182570) | NP level |
NCT00046813 | Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02147132 | Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03865121 | Pilot Trial of Transnasal Nicotine in Parkinson Disease | Parkinson disease | Nicotine (NPC182570) | NP level |
NCT04946383 | Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging | aging | Quercetin (NPC20791) | NP level |
NCT03809897 | Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02893345 | Safe@Home: A Self-Management Program for Individuals With TBI and Their Families | injury | Nicotine (NPC182570) | NP level |
NCT05060965 | Inpatient Smoking Cessation Pilot Program | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02265874 | Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study | sarcoidosis | Nicotine (NPC182570) | NP level |
NCT01478230 | An Exploratory Study Comparing Two Nicotine Inhalers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01184664 | Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study) | smoking cessation;nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04606797 | Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04020718 | Engagement With an Adaptive Mobile Health Smoking Cessation Intervention | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01989507 | Very Low-Nicotine Cigarettes in Smokers With SUD | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00332644 | Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00622752 | Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04965987 | Oxaloacetate in Myasthenia Gravis | Myasthenia gravis | Oxaloacetate (NPC1037) | NP level |
NCT04583410 | Efficacy of Nicotine in Preventing COVID-19 Infection | COVID-19;severe acute respiratory syndrome | Nicotine (NPC182570) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Quercetin (NPC20791) | NP level |
NCT01457469 | Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03989271 | Biological Effects of Quercetin in COPD | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT04648917 | GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) | esophageal cancer | Caffeic Acid (NPC294902) | NP level |
NCT02942212 | Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01406223 | Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02245308 | Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00307203 | Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01720147 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi anemia | Quercetin (NPC20791) | NP level |
NCT00064844 | Combination Nicotine Replacement for Alcoholic Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02355665 | Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01075659 | Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03243630 | Effects of Flavors on Nicotine Reinforcement in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05206435 | Methadone-Maintained Smokers Switching to E-Cigarettes | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01484717 | Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04969198 | UW Withdraw From Tobacco Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01443858 | Meclizine as a Potential Smoking Cessation Treatment | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00965913 | Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03421210 | Effects of Smoking Environments on Brain Reactivity | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03634839 | Effects of E-cigarette Flavors on Youth TCORS 2.0 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00364156 | Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03091699 | Effects of Exercise and Nicotine on Cognition in Smokers | smoking cessation | Nicotine (NPC182570) | NP level |
NCT03492463 | The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00091468 | Nicotine Treatment of Mild Cognitive Impairment (MCI) | memory impairment | Nicotine (NPC182570) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Quercetin (NPC20791) | NP level |
NCT00218296 | Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03168191 | Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2 | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00032084 | S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery | lung cancer | Nicotine (NPC182570) | NP level |
NCT05224050 | Heart Rate Variability Biofeedback for Smoking Cessation Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01476202 | Provoked Craving Relief Study by NRT | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00764439 | Pilot Study of a New Nicotine Replacement Therapy | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04521647 | Effects of Menthol in E-cigarettes on Smoking Behaviors | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01495819 | Nicotine Reinforcement and Aversion in Young Adult Light Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04974580 | Research and Innovation to Stop E-cigarette/Vaping in Young Adults | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05422885 | Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease | aging | Quercetin (NPC20791) | NP level |
NCT01058876 | Comparison of Low Yield Cigarettes in African Americans vs. Whites | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00967070 | Skin Sensitization Potential of a New Nicotine Patch | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01702519 | A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01847443 | Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04740008 | Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01438944 | Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00831155 | Extinction Based Treatment for Nicotine Dependence | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00931021 | Smoking Cessation Treatment for Head and Neck Cancer Patients | smoking cessation | Nicotine (NPC182570) | NP level |
NCT02905734 | Nicotine Replacement Therapy in Nicotine-dependent Arrestees | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00000454 | Smoking Cessation in Alcoholism Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03432312 | Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges | smoking cessation | Nicotine (NPC182570) | NP level |
NCT04126135 | Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01980550 | Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05253573 | Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02848131 | Senescence in Chronic Kidney Disease | chronic kidney disease | Quercetin (NPC20791) | NP level |
NCT00738595 | Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation. | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00701207 | Study of Nicotine Patches in Patients With Sarcoidosis | pulmonary sarcoidosis | Nicotine (NPC182570) | NP level |
NCT01050569 | Innovative Interventions for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01444131 | Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00108537 | Non-Nicotine Agents for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02162849 | Reward Sensitivity and Pharmacotherapy for Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01560507 | Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02796391 | Facilitating Smoking Cessation With Reduced Nicotine Cigarettes | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00710034 | Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02593318 | Trial of Oxaloacetate in Alzheimer's Disease (TOAD) | Alzheimer disease | Oxaloacetate (NPC1037) | NP level |
NCT00105482 | Targeted Interventions for Weight-Concerned Smokers | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT02487953 | Electronic Nicotine Delivery Systems as a Smoking Cessation Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00966901 | Photoirritation and Photoallergic Potential of a New Nicotine Patch | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00985985 | Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05301660 | Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia | schizophrenia | Nicotine (NPC182570) | NP level |
NCT01932996 | Enhancing Smoking Cessation in the Homeless Population | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00586482 | Pilot Study: Preoperative Nicotine Lozenges | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | COVID-19 | Quercetin (NPC20791) | NP level |
NCT00755716 | Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00326781 | Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT) | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01375101 | Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus | oral lichen planus | Quercetin (NPC20791) | NP level |
NCT01329614 | Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01536704 | Nicotine Lozenge Bioequivalence Study | smoking cessation | Nicotine (NPC182570) | NP level |
NCT00734617 | Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00749463 | Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT05130788 | WeChat Quit Coach Pilot Study | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01592695 | Tailored Tobacco Quitline for Rural Veterans | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04063267 | Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT00258479 | Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT01056926 | Neurobiology of Nicotine and Non-nicotine Components of Tobacco Addiction | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04033237 | Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT04535362 | Nicotine's Potential Abuse With Menthol | nicotine dependence | Nicotine (NPC182570) | NP level |
NCT03059940 | Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer | smoking cessation | Nicotine (NPC182570) | NP level |
NCT01654107 | Persistence-Targeted Smoking Cessation | nicotine dependence | Nicotine (NPC182570) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
CHRNA7,ESR2,CHRNA4,KDR,FLT3,MET,CHRFAM7A,ACHE
NCT02593318 |
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CYP1B1,MET,CA7,XDH,NOX4,MMP1,DPP4,CA12,ALOX5
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TP53,MMP2,MMP9,EGFR,MET,KDR,MMP1,SRC
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CDK1,NPSR1,NOX4,MMP1,MMP9,AURKB,ACHE,ALOX15
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CYP1A1,CA12,AURKB,CYP1A2,CYP3A4,CA2,MET,TTR
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
FLT3,TP53,NFKB1,AXL,PIM1,SRC,AURKB
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
MET,IGF1R,FLT3,TP53,MKNK2,EGFR,KDR
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
NOX4,MMP9,FLT3,MMP2,MMP1,DPP4,TSHR
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
MET,NFKB1,ACHE,DPP4,CYP19A1,CHRNA2,AXL
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
CDK1,XDH,HSD17B1,MMP1,MMP9,AURKB,CA12
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
CA4,SRC,DPP4,ACHE,HSD17B1,LMNA,CA2
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
XDH,EGFR,MMP2,CYP19A1,AXL,LMNA,CHRNA4
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CDK1,THPO,MMP1,MMP9,AURKB,CA12,CHRNA4
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
IGF1R,KDR,CSNK2A1,EGFR,MET,MKNK2
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ABCG2,MMP1,ALOX5,CA2,MMP9,NFKB1
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
KDR,AXL,IGF1R,SRC,FLT3,AHR
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
FLT3,CDK1,SRC,DPP4,TP53,AURKB
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MMP1,IGF1R,SRC,EGFR,TP53,MMP2
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NPSR1,MET,NOX4,MMP1,CYP1A1,TYR
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MET,MMP9,MMP2,KDR,EGFR
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
DPP4,ALOX5,NFKB1,FLT3,AHR
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA2,CYP2C9,CA4,CA12,CA14
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
SRC,TP53,MET,KDR,FLT3
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
AXL,TP53,AHR,EGFR,KDR
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
EGFR,TP53,MET,MMP9,KDR
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
MET,CA2,ACHE,CHRNA2,CA4
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
CHRNA7,DRD1,CHRFAM7A
NCT05301660,NCT00527020 |
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04598594,NCT04583410,NCT04853199,NCT04851821,NCT04608201
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CDK1,MMP9,HSD17B2,MMP2,CA12
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
NPSR1,NOX4,MMP1,MMP9,AURKB
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4,CHRNA7,TTR,IGF1R,ABCG2
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
CYP1B1,THPO,NOX4,MMP2,DPP4
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
KDR,SRC,TP53,FLT3
|
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
CHRNA4,CHRFAM7A,CHRNA2,CHRNA7
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
AHR,ALOX5,NFKB1,CYP3A4
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
MET,KDR,TYR,EGFR
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
KDR,SRC,MET
NCT00295984 |
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
EGFR,TP53,MET,KDR
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
CHRNA2,CHRNA7,CHRNA4,CHRFAM7A
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
AXL,SRC,TP53,EGFR
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
CES1,MET,TP53,DPP4
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
CA4,ALOX5,CHRNA7,CHRFAM7A
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT05422885,NCT04946383,NCT03408574,NCT05018117
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NCT01539434,NCT01708278,NCT03989271,NCT00132236
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4,TTR,ALOX15
NCT01912820 |
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
YES1,MMP9,CYP1A1,ACHE
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
HSD17B2,MET,AXL,ACHE
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
IGF1R,ALOX5,ACHE
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NFKB1,DPP4
NCT01839344 |
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
SRC,TP53
NCT01172561 |
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
IGF1R,XDH
NCT02848131 |
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
EGFR,KDR,FLT3
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR,KDR,MET
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
KDR,MET,EGFR
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
KDR,MET,SRC
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
KDR,ALOX5,AHR
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
MET,EGFR
NCT02893345 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
KDR,DPP4,AURKB
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
ALOX5,EGFR,CDK1
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
NFKB1,ABCG2,CHRNA4
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ACHE,CHRNA7,CHRFAM7A
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
KDR,MET,EGFR
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA4,CA12,CA2
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH,CA2
NCT00543881 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
MMP9
MMP1,MMP9 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
ESR2,AURKB
NCT01705652 |
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
NCT02955329,NCT01292642,NCT04124432
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CDK1,TSHR,CYP1A1
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR,PIM1,CYP2C9
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
MMP1,NOX4,MMP9
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
CA14,CA4,ABCG2
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
MMP1,MMP9,CYP1A1
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1,ABCG2,CHRNA3
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
FLT3,MET,AXL
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,AHR,MMP9
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
NPSR1,CHRNA3,DRD1,ACHE,CES1,CA7,POLB,AURKB,PIM1,MMP2,LMNA,AXL,CA14,XDH,CISD1,MMP1,HSD17B2,CA2,ALOX5,ABCG2,CYP1B1,MET,CYP2C9,NAPRT,TTR,DPP4,ALOX15,RECQL
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
KDR,NOX4,AHR,CHRNA3,ACHE,CA12,EGFR,TDP1,AURKB,MMP2,HSD17B10,LMNA,PSMB5,AXL,CSNK2A2,CDK1,TP53,CSNK2A1,CISD1,ESR2,MMP1,SRC,THPO,MET,TSHR,RECQL
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
MMP9,CA14,CA2,YES1,MKNK2,ALOX5,PIM1,CYP3A4,CA12,TP53,XDH,AURKB,AXL,POLB,SRC,MET,IGF1R,AHR,CDK1,CSNK2A1,FLT3,EGFR,NFKB1,CA4,KDR
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
AHR,KDR,MMP9,DRD1,CA12,CA7,EGFR,TDP1,FLT3,AURKB,PIM1,TYR,LMNA,AXL,CSNK2A2,CDK1,XDH,MMP1,HSD17B2,SRC,ALOX5,MET,DPP4,ALOX15,RECQL
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
NPSR1,CHRNA3,MMP9,CHRNA4,CA7,TDP1,POLB,AURKB,HSD17B10,PSMB5,CA14,YES1,TP53,XDH,CISD1,MMP1,HSD17B2,CYP19A1,CA2,MET,DPP4,TSHR,ALOX15
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ALOX12,NOX4,AHR,CHRNA3,MMP9,CA12,TDP1,CYP1A2,PSMB5,YES1,TP53,CSNK2A1,XDH,CISD1,MMP1,HSD17B2,CA2,ALOX5,CSNK2A3,MET,TSHR,ALOX15
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NPSR1,ALOX12,NOX4,AHR,CHRNA3,KDR,DRD1,ACHE,CA12,MMP2,CDK1,CA14,XDH,MMP1,HSD17B2,ALOX5,ABCG2,MET,CA4,CYP2C9,TTR,DPP4
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
CDK1,FLT3
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
FLT3,SRC
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
CHRNA7,CHRFAM7A
|
Dissociative neurological symptom disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B60 |
CHRFAM7A,CHRNA7
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1,ESR2
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1,ALOX5
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
CES1,ESR2
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
DPP4,THPO
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
ALOX5,FLT3
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
EGFR,MKNK2
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
CHRNA7,CHRFAM7A
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
SRC,KDR
|
NADisease Category: NADisease ICD-11 Code: NA |
MET,NOX4
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
SRC,TP53
|
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
SRC,IGF1R
|
Mental/behavioural/neurodevelopmental disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6E20-6E8Z |
CHRNA7,CHRFAM7A
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
XDH,ALOX5
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NFKB1,ESR2
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
CHRNA7,CHRFAM7A
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
CHRNA4
NCT01819259 |
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
DPP4,NFKB1
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
SRC,NFKB1
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
NCT04648917 |
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
DRD1
NCT02018263 |
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
SRC,FLT3
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53,SRC
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
ALOX5,IGF1R
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ACHE
NCT00793468 |
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR,ESR2
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
DRD1,ACHE
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
SRC,KDR
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
SRC,EGFR
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
MMP9,THPO
|
Sexual dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA00-HA01 |
CHRNA7,CHRFAM7A
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
SRC,ALOX5
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
NCT04965987 |
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT03856515,NCT05236894
|
Alcohol beverageDisease Category: X.Extension CodesDisease ICD-11 Code: XM1A61 |
NCT00699556,NCT00616746
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04598594,NCT04583410
|
SarcoidosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B20 |
NCT02265874,NCT00701207
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT03943459,NCT04907253
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT04290897,NCT03808818
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
AXL,ACHE
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
AURKB,ABCG2
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
DPP4,MMP9
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
MMP1,NOX4
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET,MMP9
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ALOX12,NOX4,CHRNA3,MMP9,IGF1R,CHRNA7,AURKB,MMP2,LMNA,CDK1,TP53,CSNK2A1,ESR2,MMP1,SRC,ALOX5,CSNK2A3,CA4
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
CHRNA4,CHRFAM7A,CHRNA7,CHRNA2
NCT05159934,NCT04262817,NCT01457469,NCT00108537,NCT01018394,NCT01351766,NCT01104896,NCT03809897,NCT00064844,NCT00000447,NCT02896400,NCT02250664,NCT02081144,NCT02501265,NCT03879889,NCT04969198,NCT03482583,NCT05233228,NCT00715871,NCT01047527,NCT00586482,NCT03442413,NCT03168191,NCT00000454,NCT02439944,NCT01506908,NCT01065506,NCT00734617,NCT00755716,NCT02232737,NCT00956943,NCT01702519,NCT00364156,NCT02271919,NCT01892813,NCT00307203,NCT03163303,NCT01907594,NCT00105482,NCT01654107,NCT00879918,NCT01429129,NCT02681510,NCT04999644,NCT00218296,NCT05351606,NCT03611881,NCT00657020,NCT03860077,NCT01091363,NCT02371850,NCT00218283,NCT05154669,NCT00749463,NCT00392379,NCT00469079,NCT00710034,NCT04521647,NCT03580525,NCT01058876,NCT01592695,NCT02721082,NCT02905734,NCT00018187,NCT01484717,NCT03421210,NCT02179034,NCT03262233,NCT01329614,NCT01048944,NCT01056926,NCT00296647,NCT03272685,NCT01314001,NCT05024747,NCT03541044,NCT01296698,NCT04020718,NCT00061074,NCT00046813,NCT04535362,NCT02511704,NCT01372254,NCT05335915,NCT01621022,NCT03634839,NCT02840435,NCT00000437,NCT01989507,NCT00000444,NCT01184664,NCT02964182,NCT00831155,NCT01034020,NCT00775944,NCT03492463,NCT00018161,NCT01867411,NCT00985985,NCT01444131,NCT01664741,NCT03538938,NCT00939029,NCT04709471,NCT01406223,NCT00507975,NCT04946825,NCT01303861,NCT01136642,NCT01783912,NCT02482233,NCT02147132,NCT00004551,NCT01199380,NCT04696380,NCT02927847,NCT01980550,NCT03635333,NCT01932996,NCT01208935,NCT01292642,NCT01560507,NCT00326781,NCT04606797,NCT03543137,NCT04033237,NCT05206435,NCT03176784,NCT04063267,NCT03612960,NCT02487953,NCT05224050,NCT03069482,NCT00664755,NCT00258479,NCT03521141,NCT04126135,NCT00888459,NCT05060965,NCT00067158,NCT01438944,NCT04740008,NCT01417429,NCT04974580,NCT03000387,NCT03243630,NCT04994444,NCT01806779,NCT04590404,NCT04003805,NCT04490057,NCT03972137,NCT05176418,NCT02019459,NCT01495819,NCT02250534,NCT02587312,NCT01050569,NCT04084210,NCT01321931,NCT02906644,NCT00132236,NCT00969137,NCT00332644,NCT01926626,NCT00086411,NCT05253573,NCT02355665,NCT05487807,NCT02162849,NCT00960778,NCT00018148,NCT02245308,NCT00777569,NCT01478230 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
IGF1R,ESR2,CA4,CA2,CA12,CDK1,CA14,EGFR,CHRNA7,CYP19A1,SRC,AXL,MET,KDR,CHRFAM7A,MKNK2
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CDK1,NOX4,CHRNA3,MMP1,CA4,MMP9,AURKB,CYP19A1,CA12,CDK1,MMP1,MMP9,AURKB,SRC,CYP19A1,CA12
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
MMP9,DRD1,ACHE,FLT3,HSD17B10,PSMB5,CISD1,NFKB1,HSD17B2,CYP3A4,CHRNA2,CYP1B1,CYP2C9,DPP4,ALOX15
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
CDK1,MET,CA7,NOX4,MMP1,CA4,CHRNA7,MMP9,AURKB,HSD17B2,CYP3A4,CYP19A1,DPP4,CA12,CHRNA4
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
MMP9,ACHE,AURKB,TYR,XDH,CYP19A1,ALOX5,MET,CYP2C9,MMP1,MMP9,AURKB,TSHR,ALOX5
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NOX4,CHRNA3,MMP9,CA12,IGF1R,CHRNA7,AURKB,MMP2,CDK1,MMP1,SRC,CYP19A1,CA4
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
NPSR1,ALOX12,MMP9,HSD17B1,CA12,CA7,CHRNA7,AURKB,CDK1,XDH,MMP1,CYP2C9,TSHR
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CA14,THPO,CHRNA3,ESR2,CHRNA7,CYP2C9,MMP9,CYP1A1,ACHE,KDM4E,ALOX15,CA2,CHRNA4
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
NPSR1,MMP9,ACHE,CA12,CA7,AURKB,CDK1,XDH,MMP1,THPO,CYP2C9,TTR,TSHR
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
EGFR,IGF1R,MET,MMP2,ALOX5,KDR,MMP9,MMP1,AXL,FLT3,CDK1
NCT00032084 |
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NOX4,CHRNA3,MMP9,ACHE,CHRNA7,CA14,XDH,MMP1,CA2,MET,CA4,TTR
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CDK1,NPSR1,XDH,MMP1,CYP2C9,MMP9,AURKB,HSD17B2,CYP1A1,ALOX15,CA2
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SRC,DRD1,CHRNA7,CHRFAM7A,ACHE
NCT03865121,NCT01560754,NCT01741701,NCT00873392,NCT00957918 |
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
NPSR1,NOX4,MMP9,DRD1,AURKB,CDK1,MMP1,CYP19A1,MET,ALOX15
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CDK1,MMP1,CYP2C9,MMP9,CYP1A2,AURKB,TTR,CYP3A4,HSD17B1,CA2
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
KDR,CA12,LMNA,CYP19A1,CA2,CYP1B1,CSNK2A3,MET,DPP4,TSHR
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
ESR2
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
CA2
|
AmyloidosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D00 |
TTR
|
Inborn metabolism deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5C59 |
CA14
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
ESR2
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
|
AbortionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA00 |
DRD1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CA2
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Aneurysm/dissectionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD50 |
CHRNA4
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
DRD1
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
CHRNA2
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
|
Synthesis disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52-5C59 |
CES1
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
EGFR
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
IGF1R
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
Digestive system diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
CHRNA4
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1
|
CardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43 |
TTR
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
AXL
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Menopausal disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA30 |
ESR2
|
Tic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05 |
DRD1
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
EGFR
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
CHRNA4
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
MMP9
|
Hypertensive crisisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA03 |
CHRNA4
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
MMP2
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NFKB1
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
EGFR
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
CA2
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
DRD1
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
CA2
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
DRD1
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
ESR2
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Peroxisomal diseaseDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C57 |
CES1
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
HypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA20-BA21 |
CHRNA4
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
CYP3A4
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
MMP2
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT05276895
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01348204
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01438320
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT01375101
|
Gastro-oesophageal reflux diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA22 |
NCT02226484
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT04733534
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT04433767
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT02720445
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT00091468
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
Congenital aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70.0 |
NCT01720147
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT04204889
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
NCT00455416
|
Immune thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.10 |
NCT02351622
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT05062486
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
NCT01517022
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
NCT00553709
|
Idiopathic pulmonary fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03.4 |
CHRNA4
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
MMP9
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
ABCG2
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
MMP9
|